vs
BICYCLE THERAPEUTICS PLC（BCYC）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
BICYCLE THERAPEUTICS PLC的季度营收约是RBB Bancorp的1.5倍（$48.0M vs $32.3M），RBB Bancorp净利率更高（31.5% vs -42.0%，领先73.5%），BICYCLE THERAPEUTICS PLC同比增速更快（1193.3% vs 12.6%），RBB Bancorp自由现金流更多（$42.6M vs $-19.9M），过去两年BICYCLE THERAPEUTICS PLC的营收复合增速更高（56.7% vs 7.0%）
Bicycle Therapeutics是一家临床阶段生物制药企业，专注于开发双环肽类创新疗法以解决未被满足的医疗需求，核心管线覆盖肿瘤、罕见病与免疫疾病领域，在欧美布局运营，与全球头部药企达成战略合作推进候选药物落地。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
BCYC vs RBB — 直观对比
营收规模更大
BCYC
是对方的1.5倍
$32.3M
营收增速更快
BCYC
高出1180.7%
12.6%
净利率更高
RBB
高出73.5%
-42.0%
自由现金流更多
RBB
多$62.5M
$-19.9M
两年增速更快
BCYC
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.0M | $32.3M |
| 净利润 | $-20.2M | $10.2M |
| 毛利率 | — | — |
| 营业利润率 | -51.5% | 39.5% |
| 净利率 | -42.0% | 31.5% |
| 营收同比 | 1193.3% | 12.6% |
| 净利润同比 | 61.1% | 132.1% |
| 每股收益（稀释后） | $-0.29 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCYCRBB
| Q4 25 | $48.0M | $32.3M | ||
| Q3 25 | $11.7M | $32.6M | ||
| Q2 25 | $2.9M | $35.8M | ||
| Q1 25 | $10.0M | $28.5M | ||
| Q4 24 | $3.7M | $28.7M | ||
| Q3 24 | $2.7M | $30.3M | ||
| Q2 24 | $9.4M | $27.5M | ||
| Q1 24 | $19.5M | $28.2M |
净利润BCYCRBB
| Q4 25 | $-20.2M | $10.2M | ||
| Q3 25 | $-59.1M | $10.1M | ||
| Q2 25 | $-79.0M | $9.3M | ||
| Q1 25 | $-60.8M | $2.3M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | $-50.8M | $7.0M | ||
| Q2 24 | $-39.8M | $7.2M | ||
| Q1 24 | $-26.6M | $8.0M |
营业利润率BCYCRBB
| Q4 25 | -51.5% | 39.5% | ||
| Q3 25 | -558.6% | 40.7% | ||
| Q2 25 | -2965.8% | 36.1% | ||
| Q1 25 | -703.7% | 11.2% | ||
| Q4 24 | — | 17.6% | ||
| Q3 24 | -2385.9% | 31.6% | ||
| Q2 24 | -498.3% | 35.6% | ||
| Q1 24 | -162.4% | 39.9% |
净利率BCYCRBB
| Q4 25 | -42.0% | 31.5% | ||
| Q3 25 | -503.7% | 31.2% | ||
| Q2 25 | -2703.8% | 26.1% | ||
| Q1 25 | -608.9% | 8.0% | ||
| Q4 24 | — | 15.3% | ||
| Q3 24 | -1898.4% | 23.1% | ||
| Q2 24 | -425.3% | 26.4% | ||
| Q1 24 | -136.0% | 28.4% |
每股收益（稀释后）BCYCRBB
| Q4 25 | $-0.29 | $0.59 | ||
| Q3 25 | $-0.85 | $0.59 | ||
| Q2 25 | $-1.14 | $0.52 | ||
| Q1 25 | $-0.88 | $0.13 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | $-0.74 | $0.39 | ||
| Q2 24 | $-0.77 | $0.39 | ||
| Q1 24 | $-0.62 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $610.0M | $523.4M |
| 总资产 | $717.6M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资BCYCRBB
| Q4 25 | $628.1M | $212.3M | ||
| Q3 25 | $648.3M | $234.9M | ||
| Q2 25 | $721.5M | $191.9M | ||
| Q1 25 | $793.0M | $238.8M | ||
| Q4 24 | $879.5M | $257.7M | ||
| Q3 24 | $890.9M | $349.4M | ||
| Q2 24 | $961.4M | $252.8M | ||
| Q1 24 | $457.0M | — |
总债务BCYCRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | — | $119.4M | ||
| Q2 24 | $30.9M | $119.3M | ||
| Q1 24 | $30.8M | $119.2M |
股东权益BCYCRBB
| Q4 25 | $610.0M | $523.4M | ||
| Q3 25 | $618.5M | $514.3M | ||
| Q2 25 | $668.9M | $517.7M | ||
| Q1 25 | $740.3M | $510.3M | ||
| Q4 24 | $793.1M | $507.9M | ||
| Q3 24 | $831.0M | $509.7M | ||
| Q2 24 | $873.8M | $511.3M | ||
| Q1 24 | $356.0M | $514.0M |
总资产BCYCRBB
| Q4 25 | $717.6M | $4.2B | ||
| Q3 25 | $764.0M | $4.2B | ||
| Q2 25 | $832.2M | $4.1B | ||
| Q1 25 | $883.9M | $4.0B | ||
| Q4 24 | $956.9M | $4.0B | ||
| Q3 24 | $996.7M | $4.0B | ||
| Q2 24 | $1.1B | $3.9B | ||
| Q1 24 | $547.1M | $3.9B |
负债/权益比BCYCRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | 0.04× | 0.23× | ||
| Q1 24 | 0.09× | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.3M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $42.6M |
| 自由现金流率自由现金流/营收 | -41.5% | 131.8% |
| 资本支出强度资本支出/营收 | 1.2% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-252.0M | $73.5M |
8季度趋势，按日历期对齐
经营现金流BCYCRBB
| Q4 25 | $-19.3M | $43.4M | ||
| Q3 25 | $-71.2M | $2.1M | ||
| Q2 25 | $-72.8M | $21.7M | ||
| Q1 25 | $-86.4M | $7.8M | ||
| Q4 24 | $-164.7M | $58.5M | ||
| Q3 24 | $-39.8M | $24.5M | ||
| Q2 24 | $-44.6M | $11.7M | ||
| Q1 24 | $-70.9M | $4.8M |
自由现金流BCYCRBB
| Q4 25 | $-19.9M | $42.6M | ||
| Q3 25 | $-71.8M | $1.8M | ||
| Q2 25 | $-73.3M | $21.6M | ||
| Q1 25 | $-87.0M | $7.6M | ||
| Q4 24 | $-166.0M | $57.7M | ||
| Q3 24 | $-40.3M | $24.2M | ||
| Q2 24 | $-45.0M | $11.5M | ||
| Q1 24 | $-70.9M | $4.7M |
自由现金流率BCYCRBB
| Q4 25 | -41.5% | 131.8% | ||
| Q3 25 | -612.3% | 5.4% | ||
| Q2 25 | -2509.7% | 60.2% | ||
| Q1 25 | -871.7% | 26.7% | ||
| Q4 24 | -4475.7% | 201.0% | ||
| Q3 24 | -1504.7% | 80.0% | ||
| Q2 24 | -481.2% | 42.0% | ||
| Q1 24 | -362.9% | 16.6% |
资本支出强度BCYCRBB
| Q4 25 | 1.2% | 2.5% | ||
| Q3 25 | 5.7% | 1.1% | ||
| Q2 25 | 17.1% | 0.3% | ||
| Q1 25 | 6.1% | 0.6% | ||
| Q4 24 | 33.3% | 2.7% | ||
| Q3 24 | 16.3% | 0.8% | ||
| Q2 24 | 4.5% | 0.5% | ||
| Q1 24 | 0.1% | 0.5% |
现金转化率BCYCRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
